Dynamic Flowsheet Model Development and Sensitivity Analysis of a Continuous Pharmaceutical Tablet Manufacturing Process Using the Wet Granulation Route
Abstract:In view of growing interest and investment in continuous manufacturing, the development and utilization of mathematical model(s) of the manufacturing line is of prime importance. These models are essential for understanding the complex interplay between process-wide critical process parameters (CPPs) and critical quality attributes (CQAs) beyond the individual process operations. In this work, a flowsheet model that is an approximate representation of the ConsiGma TM -25 line for continuous tablet manuf… Show more
“…Metta et al (2019) performed design and dynamic simulation of a continuous tableting line (composed of feeders, blenders, wet granulation, fluidized bed drying, milling + tablet press). The authors elucidated the critical process parameters affecting product quality that needed to be ensured in order to facilitate robust process design [35].…”
Section: Continuous Downstream Processing + Drug Product Formulationmentioning
Progress in continuous flow chemistry over the past two decades has facilitated significant developments in the flow synthesis of a wide variety of Active Pharmaceutical Ingredients (APIs), the foundation of Continuous Pharmaceutical Manufacturing (CPM), which has gained interest for its potential to reduce material usage, energy and costs and the ability to access novel processing windows that would be otherwise hazardous if operated via traditional batch techniques. Design space investigation of manufacturing processes is a useful task in elucidating attainable regions of process performance and product quality attributes that can allow insight into process design and optimization prior to costly experimental campaigns and pilot plant studies. This study discusses recent demonstrations from the literature on design space investigation and visualization for continuous API production and highlights attainable regions of recoveries, material efficiencies, flowsheet complexity and cost components for upstream (reaction + separation) via modeling, simulation and nonlinear optimization, providing insight into optimal CPM operation.
“…Metta et al (2019) performed design and dynamic simulation of a continuous tableting line (composed of feeders, blenders, wet granulation, fluidized bed drying, milling + tablet press). The authors elucidated the critical process parameters affecting product quality that needed to be ensured in order to facilitate robust process design [35].…”
Section: Continuous Downstream Processing + Drug Product Formulationmentioning
Progress in continuous flow chemistry over the past two decades has facilitated significant developments in the flow synthesis of a wide variety of Active Pharmaceutical Ingredients (APIs), the foundation of Continuous Pharmaceutical Manufacturing (CPM), which has gained interest for its potential to reduce material usage, energy and costs and the ability to access novel processing windows that would be otherwise hazardous if operated via traditional batch techniques. Design space investigation of manufacturing processes is a useful task in elucidating attainable regions of process performance and product quality attributes that can allow insight into process design and optimization prior to costly experimental campaigns and pilot plant studies. This study discusses recent demonstrations from the literature on design space investigation and visualization for continuous API production and highlights attainable regions of recoveries, material efficiencies, flowsheet complexity and cost components for upstream (reaction + separation) via modeling, simulation and nonlinear optimization, providing insight into optimal CPM operation.
“…The manufacturing system can be made more productive and efficient through the adoption of data science analysis methods. In the recent years, the continuous tablet manufacturing system is one of the most notable applications of data science-driven innovation [11]. The genomic data analysis-based development of drugs is used in clinical practice to reduce the cost of gathering the three billion human DNA [24].…”
Section: Literature Reviewmentioning
confidence: 99%
“…In the last 10 years, rapid changes in innovation have occurred as a result of improvements in data availability and computational ability. This innovation is a part of the "fourth industrial revolution," which combines technologies and blends advanced services based on data science [6][7][8][9][10][11][12][13][14]. In detail, data science shows many possibilities of improving productivity and adopting new business models with promising technologies, such as wireless sensor networking, big data, artificial intelligence, cloud-based services, and so forth.…”
The pharmaceutical industry is one of the most research and development (R&D)-intensive industries. This industry has tried many strategies to overcome the limitations of a business model that had a high return and high risk. In recent years, the fourth industrial revolution has affected many industries, causing them to update their traditional production and business strategies to a “data science-based” approach. This data science methodology, based on the largely increased size of the data environment, has actively changed the pharmaceutical industry. Therefore, this study aimed to identify specific characteristics of data science innovation in the pharmaceutical industry through the analysis of patent data from the triadic patent databases from the United States, Japan, and Europe.
“…Several authors have covered the entire manufacturing process. Flowsheet models have been developed to predict dynamics for processes based on direct compression [16], dry granulation [17], and wet granulation [18]. Singh et al developed a control strategy for dry granulation and implemented it into a process-wide flowsheet based on firstprinciples models [19].…”
This paper presents a new method for process synthesis and economic assessment for solid drug product manufacturing, considering continuous manufacturing as a prominent process alternative. Of the three phases of drug development, phase II was targeted where the dosage form, formulation, and processing technology are determined. For a comprehensive alternative generation, a superstructure was developed that covered 9452 options for the unit level, which was combined with two options on the formulation strategy. The generated alternative was assessed by a net present value calculation model, which was adapted for dynamic cash flow consideration in the drug lifecycle. The model can incorporate uncertainty in the drug development and manufacturing in the result, and can perform global sensitivity analysis by Monte Carlo simulation. The method was demonstrated in a case study where two different scenarios regarding the price of the active pharmaceutical ingredient and the demand for the product were assumed. The results showed that when the demand and price are both low, the labor-related costs are dominant, and in the opposite case, the material-related costs become relevant. We also introduce the prototype version of the software "SoliDecision," by which the presented method was implemented for industrial application.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.